Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kewen Qian

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Mabs|June 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemicKewen Qian, Shi Hu
Journal of Experimental & Clinical Cancer Research : CR|September 27, 2022
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapyKewen Qian, Wenyan Fu, Tian Li, et al.
Theranostics|July 13, 2023
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequencyWenyan Fu, Guangyao Li, Changhai Lei, et al.
Nature Communications|April 26, 2020
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-IgChanghai Lei, Kewen Qian, Tian Li, et al.
Frontiers in Immunology|August 9, 2021
CAR Macrophages for SARS-CoV-2 ImmunotherapyWenyan Fu, Changhai Lei, Zetong Ma, et al.
Frontiers in Immunology|February 6, 2023
Engineered soluble ACE2 receptor: Responding to change with changeGuangyao Li, Kewen Qian, Shuyi Zhang, et al.
View (Beijing, China)|November 12, 2021
Therapeutic antibodies under development for SARS-CoV-2Zetong Ma, MengMei Zhu, Shuyi Zhang, et al.
Frontiers in Immunology|July 23, 2024
The therapeutic potential of exosomes in immunotherapyGuangyao Li, Shuyi Zhang, Yitan Zou, et al.
Journal of Drug Targeting|January 2, 2024
Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type AYongpeng Wei, Guangyao Li, Zhuo Wang, et al.
Frontiers in Immunology|March 12, 2024
Small extracellular vesicles purification and scale-upXinya Zheng, Hongru Ai, Kewen Qian, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Mabs|June 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemicKewen Qian, Shi Hu
Journal of Experimental & Clinical Cancer Research : CR|September 27, 2022
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapyKewen Qian, Wenyan Fu, Tian Li, et al.
Theranostics|July 13, 2023
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequencyWenyan Fu, Guangyao Li, Changhai Lei, et al.
Nature Communications|April 26, 2020
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-IgChanghai Lei, Kewen Qian, Tian Li, et al.
Frontiers in Immunology|August 9, 2021
CAR Macrophages for SARS-CoV-2 ImmunotherapyWenyan Fu, Changhai Lei, Zetong Ma, et al.
Frontiers in Immunology|February 6, 2023
Engineered soluble ACE2 receptor: Responding to change with changeGuangyao Li, Kewen Qian, Shuyi Zhang, et al.
View (Beijing, China)|November 12, 2021
Therapeutic antibodies under development for SARS-CoV-2Zetong Ma, MengMei Zhu, Shuyi Zhang, et al.
Frontiers in Immunology|July 23, 2024
The therapeutic potential of exosomes in immunotherapyGuangyao Li, Shuyi Zhang, Yitan Zou, et al.
Journal of Drug Targeting|January 2, 2024
Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type AYongpeng Wei, Guangyao Li, Zhuo Wang, et al.
Frontiers in Immunology|March 12, 2024
Small extracellular vesicles purification and scale-upXinya Zheng, Hongru Ai, Kewen Qian, et al.
Pageof 2